Search

everythinglearnresearchcommunity

for

Search:↓

Scientists discovered a unique hair protein, KAP24.1, with a special structure, found only in the upper part of hair cuticles.

Improving CRISPR/Cas systems can make gene editing more efficient and precise.

S100A6 protein is linked to disease progression, especially in cancers.

RNA delivery is best for in-body use, while RNP delivery is good for outside-body use. Both methods are expected to greatly impact future treatments.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Blocking YAP/TAZ could be a new way to treat skin cancer.

Nanotechnology improves CRISPR-Cas9 delivery for cancer treatment, but challenges remain.

Peptide-based hydrogels are promising for healing chronic wounds effectively.

The androgen receptor's shape-changing ability helps it function but can lead to cancer treatment resistance.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Biopolymers are increasingly used in cosmetics for their non-toxicity and skin benefits, with future biotech advancements likely to expand their applications.

A specific chemical change in the S100A3 protein leads to the formation of a four-part structure important for hair formation.

Lipases, especially gehB, are crucial for Staphylococcus aureus to enter and colonize hair follicles.

The hydrogel effectively heals wounds and fights bacteria.

Environmental factors can cause mutations in skin proteins, leading to skin disorders.

Compound 7p shows strong potential as an anticancer agent.

Microneedles improve drug delivery for skin diseases, enhancing treatment effectiveness and patient compliance.

New compounds show promise as nonsteroidal treatments for hair loss.

Biological factors are crucial for developing new hair restoration treatments.

Efficient delivery systems are needed for the clinical use of CRISPR-Cas9 gene editing.

N-oxides are important in medicine for improving drug properties and targeting.

New CRISPR/Cas9 variants and nanotechnology-based delivery methods are improving cancer treatment, but choosing the best variant and overcoming certain limitations remain challenges.

Low Vitamin D receptor levels in breast cancer are linked to worse outcomes and more bone metastases, and could be a marker for prognosis.

Brimonidine is effective for reducing facial redness in skin conditions and has potential for broader dermatological uses.

Chemistry42 effectively creates and optimizes new molecules for drug discovery.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

Microfluidic technology improves cell spheroid creation for better drug testing and tissue engineering.

Nanotechnology shows promise for better chronic wound healing but needs more research.

ERULUS controls root hair growth by regulating cell wall composition and pectin activity.

Mutations in the vitamin D receptor cause hereditary vitamin D-resistant rickets, leading to poor bone health and requiring high calcium doses for treatment.